Vaccinex (VCNX) Tops Q1 EPS by 20c
Tweet
Share
E-mailGet Alerts VCNX Hot Sheet
Join SI Premium – FREE
Vaccinex (NASDAQ: VCNX) reported Q1 EPS of ($0.10), $0.20 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $550 thousand versus the consensus estimate of $0 .
For earnings history and earnings-related data on Vaccinex (VCNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
